U.S. - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAntisera Prices in the United States
U.S. Antisera Import Price per Ton in June 2022
In June 2022, the antisera price per ton stood at $3.0M (CIF, US), rising by 79% against the previous month. Overall, the import price showed a significant increase. The most prominent rate of growth was recorded in March 2022 when the average import price increased by 94% month-to-month. The import price peaked in June 2022.
Prices varied noticeably by the country of origin: the country with the highest price was Ireland ($35.0M per ton), while the price for Poland ($11.6K per ton) was amongst the lowest.
From January 2022 to June 2022, the most notable rate of growth in terms of prices was attained by Finland (+136.9%), while the prices for the other major suppliers experienced more modest paces of growth.
U.S. Antisera Imports
In August 2022, after two months of decline, there was significant growth in overseas purchases of antisera and other blood fractions, when their volume increased by 23% to 1.8K tons. Over the period under review, imports, however, continue to indicate a abrupt slump.
In value terms, antisera imports surged to $4.2B (IndexBox estimates) in August 2022. In general, imports, however, continue to indicate a perceptible reduction. The most prominent rate of growth was recorded in May 2022 with an increase of 21% m-o-m.
U.S. Antisera Imports by Country
In June 2022, Canada (609 tons) constituted the largest antisera supplier to the United States, accounting for a 40% share of total imports. Moreover, antisera imports from Canada exceeded the figures recorded by the second-largest supplier, Germany (178 tons), threefold. The third position in this ranking was taken by Poland (90 tons), with a 5.9% share.
From January 2022 to June 2022, the average monthly growth rate of volume from Canada totaled +1.1%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (+4.5% per month) and Poland (+259.4% per month).
In value terms, Ireland ($1.7B) constituted the largest supplier of antisera to the United States, comprising 37% of total imports. The second position in the ranking was held by Germany ($439M), with a 9.8% share of total imports. It was followed by Switzerland, with an 8.7% share.
From January 2022 to June 2022, the average monthly growth rate of value from Ireland stood at +5.8%. The remaining supplying countries recorded the following average monthly rates of imports growth: Germany (-6.0% per month) and Switzerland (-1.7% per month).
This report provides an in-depth analysis of the antisera market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions
Country coverage:
- United States
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the U.S.
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2024
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2024
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Per Capita Consumption In 2012-2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2024
- Market Value, 2012–2024
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2024
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2024
- Trade Balance, In Physical Terms, 2012-2024
- Trade Balance, In Value Terms, 2012-2024
- Per Capita Consumption, 2012-2024
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2024
- Production, In Value Terms, 2012–2024
- Imports, In Physical Terms, 2012–2024
- Imports, In Value Terms, 2012–2024
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country, 2012–2024
- Imports, In Value Terms, By Country, 2012–2024
- Import Prices, By Country Of Origin, 2012–2024
- Exports, In Physical Terms, 2012–2024
- Exports, In Value Terms, 2012–2024
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country, 2012–2024
- Exports, In Value Terms, By Country, 2012–2024
- Export Prices, By Country Of Destination, 2012–2024
434
This report provides an in-depth analysis of the antisera market in the U.S..
529
This report provides an in-depth analysis of the biological product market in the U.S..
462
This report provides an in-depth analysis of the vaccine market in the U.S..
328
This report provides an in-depth analysis of the veterinary medicine vaccines market in the U.S..
387
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
1979
This report provides an in-depth analysis of the global antisera market.
424
This report provides an in-depth analysis of the global biological product market.
2589
This report provides an in-depth analysis of the global vaccine market.
640
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
491
This report provides an in-depth analysis of the global market for human and animal blood.
112
Haleon invests $54M in its U.S. R&D centre to drive innovation in consumer healthcare, enhancing its product pipeline and maintaining competitive edge.
595
For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by...
112
U.S. experts predict a smaller winter COVID wave, posing challenges for Pfizer amid declining revenues, emphasizing the need to diversify non-COVID products.
240
Explore Moderna's ongoing phase three norovirus vaccine trial targeting urgent prevention needs amid rising outbreaks in the U.S.
207
Moderna has secured $590 million to enhance pandemic influenza vaccine development, focusing on mRNA technology and expanding human trials.
91
Moderna's shares increased by over 10% due to progress in H5N1 vaccine development following a human fatality in the U.S.
65
In the period of 2018 to 2024, the growth of exports for Human And Animal Blood failed to regain momentum. The value of exports declined to $3.5B in 2024.
1356
From February 2023 to December 2023, the exports of Human And Animal Blood saw a significant decline, dropping to $71M in value.
81
Spanish drugmaker Grifols SA navigates a challenging year with strategic shifts and investor concerns, aiming to stabilize financially and regain market confidence.
218
The article provides insights into the anticipated growth of the global market for antisera and other blood fractions over the next seven years, driven by increasing demand. Market performance is forecasted to expand with a CAGR of +1.7% in volume terms and +6.5% in value terms, reaching 707K tons and $580.4B respectively by the end of 2030.
